In vitro and pathological investigations of MODY5 with the R276X-HNF1β (TCF2) mutation

被引:10
|
作者
Fujimoto, Kei [3 ]
Sasaki, Takashi [3 ]
Hiki, Yoshito [3 ]
Nemoto, Masami
Utsunomiya, Yasunori [1 ,3 ]
Yokoo, Takashi [3 ]
Nakai, Nozomu [1 ]
Ohashi, Toya [2 ]
Hosoya, Tatsuo [3 ]
Eto, Yoshikatsu [2 ]
Tajima, Naoko [1 ]
机构
[1] Jikei Univ, Sch Med, Div Endocrinol Diabet & Metab, Dept Internal Med,Minato Ku, Tokyo 1058461, Japan
[2] Jikei Univ, Sch Med, Dept Gene Therapy, Inst DNA Med, Tokyo 1058461, Japan
[3] Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens, Tokyo 1058461, Japan
关键词
MODY; polycystic kidney; RCAD; TCF2;
D O I
10.1507/endocrj.K07-051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Maturity-onset diabetes of the young type 5 (MODY5) is caused by mutation of hepatocyte nuclear factor I P (HNF1 beta) (TCF2) gene, resulting in a wide range of phenotypes including diabetes and renal abnormalities, but little is known about the pathogenesis of the clinical spectrum. We describe a 27-year-old Japanese male with the MODY phenotype including an atrophic kidney and multiple renal cysts. Genetic analysis revealed the patient to be heterozygous for a nonsense mutation in codon 276 of the HNF1 beta gene (CGA or Arginine to TGA or stop codon; R276X). To clarify the pathophysiological relevance of this mutation, we conducted an in vitro study monitoring human C-peptide secretion after transfecting both the HNF1 beta mutant cDNA and preproinsulin cDNA into a murine P cell line, MIN6. Functional studies of the transformed MIN6 cells indicated that expression of the R276X caused a significant decrease in glucose-stimulated insulin secretion but no change in either KCI-stimulated or basal insulin secretion. These results suggest that the R276X functions in a negative manner in regard to metabolic responses of insulin secretion in P cells. Analysis with light and electron microscopy on biopsied kidney specimens suggested that the origin of the cysts might be glomeruli but the primary lesion could be tubules.
引用
收藏
页码:757 / 764
页数:8
相关论文
共 22 条
  • [1] Genotype-phenotype inconsistency in a MODY5 family with a new mutation in the TCF2 gene, encoding hepatocyte nuclear factor 1-beta (HNF1beta): Is MODY5 a multifactorial disease?
    Konrad, D
    Lang-Muritano, M
    Vaccaro, T
    Schoenle, EJ
    Biason-Lauber, A
    DIABETES, 2005, 54 : A280 - A281
  • [2] Hnf6 and Tcf2 (MODY5) are linked in a gene network operating in a precursor cell domain of the embryonic pancreas
    Maestro, MA
    Boj, SF
    Luco, RF
    Pierreux, CE
    Cabedo, J
    Servitja, JM
    German, MS
    Rousseau, GG
    Lemaigre, FP
    Ferrer, J
    HUMAN MOLECULAR GENETICS, 2003, 12 (24) : 3307 - 3314
  • [3] Spontaneous mutation of the TCF2 gene as a cause of maturity-onset diabetes of the young type 5 (MODY5) - case report
    Zmurowska, Barbara
    Szymczyk, Agnieszka
    Darda, Marta
    Kanas, Natalia
    Pabisz, Monika
    Szczesniak, Anna
    Jaroszynski, Andrzej
    CLINICAL DIABETOLOGY, 2015, 4 (04): : 141 - 146
  • [4] Hypomagnesemia linked to a mutation of TCF2 revealing MODY 5 type diabetes
    Quintin, D.
    Balavoine, A. -S.
    Hobert, C.
    Heidet, L.
    Antignac, C.
    Vargas-Poussou, R.
    Vantyghem, M. -C.
    DIABETES & METABOLISM, 2011, 37 : A66 - A66
  • [5] A novel mutation of HNF1B gene identified in MODY5
    Fujita, Y.
    Hyo, T.
    Yamazaki, Y.
    Matsubara, M.
    Hamamoto, Y.
    Komiya, T.
    Tanaka, D.
    Seino, Y.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S151 - S151
  • [6] Mutation in hepatocyte nuclear factor–1β gene (TCF2) associated with MODY
    Yukio Horikawa
    Naoko Iwasaki
    Manami Hara
    Hiroto Furuta
    Yoshinori Hinokio
    Brian N. Cockburn
    Tom Lindner
    Kazuya Yamagata
    Makiko Ogata
    Osamu Tomonaga
    Hiroyuki Kuroki
    Tadasu Kasahara
    Yasuhiko Iwamoto
    Graeme I. Bell
    Nature Genetics, 1997, 17 : 384 - 385
  • [7] Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY
    Horikawa, Y
    Iwasaki, N
    Hara, M
    Furuta, H
    Hinokio, Y
    Cockburn, BN
    Lindner, T
    Yamagata, K
    Ogata, M
    Tomonaga, O
    Kuroki, H
    Kasahara, T
    Iwamoto, Y
    Bell, GI
    NATURE GENETICS, 1997, 17 (04) : 384 - 385
  • [8] Hypomagnesaemia revealing Maturity Onset Diabetes of the Young (MODY) type 5 linked to TCF2 mutation
    Quintin, D.
    Balavoine, A. -S.
    Hober, C.
    Heidet, L.
    Antignac, C.
    Vargas-Poussou, R.
    Vantyghem, M. -C.
    DIABETOLOGIA, 2010, 53 : S117 - S117
  • [9] New clinical and molecular features of heterozygous 17q12 deletion syndrome, leading to loss of TCF2 and MODY5
    Raile, Klemens
    Wessel, Theda
    Mueller, Dominik
    Horn, Denise
    Ullmann, Reinhard
    Klopocki, Eva
    Grueters, Annette
    EUROPEAN JOURNAL OF PEDIATRICS, 2008, 167 (03) : 363 - 364
  • [10] Phenotypic heterogenity of TCF2's gene mutation coding for HNF-1β in a single family
    Rigothier, Claire
    Harambat, Jerome
    Llanas, Brigitte
    Subra, Jean-Francois
    Combe, Christian
    NEPHROLOGIE & THERAPEUTIQUE, 2009, 5 (04): : 287 - 291